Opexa Therapeutics, Inc.

Release Summary

Opexa Therapeutics today announced that its Board of Directors approved a 1-for-4 reverse stock split of its common stock, effective immediately following the close of trading December 14, 2012.

Opexa Therapeutics, Inc.